Concepedia

Ian Christie

IC

Statistics

Publications

2

Citations

66

H-Index

2

Active since

2017

Affiliations

UPMC Hillman Cancer Center(Current)

Ian Christie is an author at UPMC Hillman Cancer Center specializing in therapeutic resistance mechanisms, therapeutic resistance, and medicine.

Publications per year

2017–2017

2

Publications

2

Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in <i>KRAS-</i> Mutant NSCLC Is Mediated via Reactivation of the ERK–p90RSK–mTOR Signaling Network

Suman Chatterjee, Eric H.‐B. Huang, Ian Christie et al. · Molecular Cancer Therapeutics · 2017 · 48 citations · Full text

, , +17

Reactivation of the p90RSK–CDC25C Pathway Leads to Bypass of the Ganetespib-Induced G2–M Arrest and Mediates Acquired Resistance to Ganetespib in <i>KRAS</i> -Mutant NSCLC

Suman Chatterjee, Eric H.‐B. Huang, Ian Christie et al. · Molecular Cancer Therapeutics · 2017 · 18 citations · Full text

, , +17

1–2 of 2